Metastasiertes Mammakarzinom: Erhaltung mit Capecitabin plus Bevacizumab
Crossref DOI link: https://doi.org/10.1007/s15015-015-1655-y
Published Online: 2015-03-19
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kreutzkamp, Barbara
Text and Data Mining valid from 2015-03-01